Contract 75A50122D00004
Seqirus Inc · Department Of Health And Human Services · February 18, 2022
Seqirus Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on February 18, 2022 for an undisclosed amount of work in biological product (except diagnostic) manufacturing. It was awarded under full and open competition. The contract has been modified 14 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 24, 2026. If all options are exercised, the contract could reach $13.40 billion.
Contract details
- PIID
- 75A50122D00004
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- February 18, 2022
- Latest action
- March 24, 2026
Description
(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE
Modification timeline
-
March 24, 2026Mod P00014(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
December 12, 2025Mod P00013(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
November 20, 2025Mod P00012(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
October 14, 2025Mod P00011(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
June 12, 2025Mod P00010(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
May 8, 2025Mod P00009(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
January 21, 2025Mod P00008(1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNAT$0
-
March 13, 2024Mod P00007THIS MODIFICATION UPDATES ARTICLE H.3 HHSAR 352.237-75 KEY PERSONNEL- REPLACING PAYAL PATEL, HEAD, PMO AND OPERATIONAL GOVERNANCE WITH MARIA LACOURT-CUEVAS, HEA$0
-
July 6, 2023Mod P00006THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO ADD FAR CLAUSE 52.204-27, PROHIBITION ON A BYTEDANCE COVERED APPLICATION TO ARTICLE I.1. FAR 52.252-2, CLA$0
-
March 6, 2023Mod P00005THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO UPDATE THE KEY PERSONNEL TO REFLECT RECENT STAFF CHANGES.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
| Life Technologies Corporation | Department Of Health And Human Services | March 17, 2026 | $18.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50122D00004?
Contract 75A50122D00004 is a federal contract awarded to Seqirus Inc by Department Of Health And Human Services on February 18, 2022 for an undisclosed amount of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 14 times since the base award.
Who won contract 75A50122D00004?
Seqirus Inc won contract 75A50122D00004 from Department Of Health And Human Services.
How much is contract 75A50122D00004 worth?
Contract 75A50122D00004 has obligated $0 to date but carries a potential ceiling of $13.40 billion if fully funded and all options are exercised.